Prophylactic Migraine Treatments

Warning

Treatment choice should be tailored to the individual patient dependant on their co-morbidities and lifestyle. There is no one treatment better than another. A reduction of 30-50% in headache severity or frequency is considered a successful treatment.  As above, a headache diary should be provided to help quantify this improvement. All treatments should be trialled for at least 3 months at target dose before considering efficacy.

 

Starting Dose

Dose Regimen

Target Dose

Propanalol

10-20mg twice daily

Increase 10-20mg twice daily every 1-2 weeks

80mg twice daily

Amitriptyline

10mg at night (few hours before bed)

Increase 10mg every 2 weeks

30-50 daily (max dose 100mg daily)

Nortriptyline

No formal evidence but less sedating than Amitriptyline so may be considered if Amitriptyline limited by somnolence

Candesartan

4mg once daily

Increase 4mg every 2 weeks

16mg daily

Topiramate

25mg once daily

Increase 25mg every 2 weeks

50-100mg twice daily

Women and topiramate

Women of child-bearing age must be warned of teratogenicity of Topiramate and be on highly effective contraception

Atogepant (1st line CGRP)

60mg once daily

60mg once daily

60mg once daily

Rimegepant (2nd line CGRP)

75mg alternate days

75mg alternate days

75mg alternate days

Further information

National Headache Pathway - Migraine Prophylaxis

Editorial Information

Next review date: 05/01/2027